Work

Sacituzumab tirumotecan improved survival for patients with EGFR TKI–resistant, EGFR‐mutant advanced NSCLC

Year: 2026
Type: article
Source: Cancer
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W7130584227
FWCI: 4.618
Cites: 5
Cited by: 1
Related to: